Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate if retarded release phosphatidylcholine is an effective alternative to steroid dependent or -refractory course in chronic active ulcerative colitis. The hypot...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Heidelberg University
Collaborators
NCT07550673 · Acute Severe Ulcerative Colitis
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07374471 · Ulcerative Colitis (UC)
NCT05739864 · Active Ulcerative Colitis
NCT06071312 · Clostridium Difficile, Ulcerative Colitis
University Heidelberg - Medical Department 4 - Gastroenterology
Heidelberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions